Richard W. Paul & Associates’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$2.87K Hold
2024
Q3
$2.79K Hold
2024
Q2
$3.18K Hold
2024
Q1
$4.23K Buy